imfinzi infusion conc (vial) 120 mg-2-4 ml
Imfinzi infusion conc (vial) 120 mg/2.4 mL (120 mg/2.4 mL)
Manufacturer:
AstraZeneca
Distributor:
Zuellig Pharma
Contents:
durvalumab
MIMS Class:
Cancer Immunotherapy
Form:
Vial
Shape:
Undefined